Exploring plant-derived peptides for cancer treatment
Discovery, Biosynthesis and Engineering of Side-Chain-Macrocyclic Plant Peptides
This study is exploring how natural plant proteins might help in treating cancer, and it's for anyone interested in new, nature-based therapies that could improve cancer care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11076705 on NIH RePORTER |
What this research studies
This research focuses on discovering and engineering plant peptides that could be used in cancer therapy. By utilizing advanced techniques in plant biology and synthetic biology, the team aims to identify new plant metabolites and produce them in a lab setting. The approach includes analyzing plant extracts using mass spectrometry and modifying genetic pathways to create effective analogs of these peptides. This could lead to the development of new, effective treatments for cancer that are derived from natural sources.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who are seeking novel treatment options.
Not a fit: Patients who do not have cancer or are not interested in experimental therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective cancer therapies derived from plant peptides.
How similar studies have performed: Other research has shown promise in using plant-derived compounds for therapeutic purposes, indicating potential success for this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Kersten, Roland David — University of Michigan at Ann Arbor
- Study coordinator: Kersten, Roland David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.